There is a habit in small states, and Lesotho is hardly unique in this, of dressing up irrational suspicion in the language of constitutional principle. The controversy surrounding the 2025–2030 U.S.–Lesotho health Memorandum of Understanding is a masterclass in this genre.
Strip away the legalese and the sovereignty rhetoric and what remains is something far less sophisticated: utopian fantasy, procedural obstruction, and a barely concealed ideological hostility toward the United States that is costing Lesotho lives while its critics congratulate themselves on their principles.
The Data Sovereignty Argument Does Not Hold
The most dishonest move in the critics’ playbook is the pretence that this MoU represents an unprecedented intrusion into Lesotho’s data sovereignty. It does not. Lesotho has been sharing health data with external partners for decades.
The data is already flowing. The systems are already integrated. The partnerships are already deep. The only honest question is whether Lesotho formalises and improves that relationship with clear timelines, co-investment benchmarks, and mutual accountability, or retreats into sovereignty mythology while its HIV and TB programmes slowly unravel.
Two Drivers of the Mythology
The first is utopian thinking: the fantasy that Lesotho could, if only it refused American partnership, build an entirely self-sufficient, domestically financed, nationally controlled health system untouched by foreign leverage. Lesotho’s own sustainability roadmaps acknowledge the yawning gap between what the state can finance and what the health system requires.
The critics offer no alternative financing. No substitute for PEPFAR’s antiretroviral coverage. No replacement for CDC’s laboratory systems. No funding stream to maintain the digital infrastructure they are now suddenly so concerned to protect. Their sovereignty argument is sovereignty for its own sake, a position so abstract it can only be held by people who will not personally suffer when the funding stops.
“Their sovereignty argument is sovereignty for its own sake, a position so abstract it can only be held by people who will not personally suffer when the funding stops.”
Lesotho Tribune EditorialThe second driver is uglier: a selective, ideological hostility toward the United States that masquerades as principled anti-imperialism. Critics of this MoU are not publishing lengthy analyses of the Global Fund’s grant conditions, which are genuinely tough, explicitly audit-heavy, and tied to performance benchmarks. They are not staging parliamentary dramas over WHO’s engagement with Lesotho’s health information systems. They reserve their outrage specifically and conspicuously for the American agreement. That selectivity is not principle. It is prejudice.
On Specimen-Sharing and the Constitutional Argument
The 25-year data and specimen-sharing arrangement that critics find so alarming is not a colonial imposition. It is a long-term planning horizon for a country dealing with a generational HIV and TB burden. Every serious public health actor in the world, including WHO, advocates for rapid specimen-sharing and genomic surveillance precisely because slow, territorially jealous responses cost lives.
The constitutional argument, that the Tenth Amendment required parliamentary approval before the MoU was signed, deserves more respect than the anti-American conspiracy thinking, but not as much as its proponents claim. The MoU’s own text says explicitly that it is not an international agreement and does not create legal rights or obligations under international or domestic law. If the document is not legally binding, then the parliamentary approval requirement, designed for binding treaties, is not obviously triggered. The critics want to use constitutional procedure to block the agreement while simultaneously arguing that its legal self-description must be ignored. That is not rigorous constitutional analysis. It is strategic proceduralism in service of a predetermined conclusion.
The Questions That Demand Answers
While this performative debate continues, Lesotho’s health system remains dependent on external financing that is not guaranteed beyond current cycles. The HIV epidemic is not pausing for parliamentary review. TB continues to kill. Laboratory systems need maintenance. Health workers need salaries.
- Which partner will replace U.S. financing for laboratory systems?
- Which country will provide technical assistance for DHIS2?
- Who will fund antiretroviral treatment for Basotho living with HIV if PEPFAR coverage is reduced during a period of no formal agreement?
- Where does the domestic budget line for specimen transport, cold chain maintenance, and health information system upgrades come from?
The silence in response to these questions is not principled. It is the silence of people who have elevated ideological purity over practical governance, who have mistaken obstruction for sovereignty, and whose utopian resistance to American partnership is, in the most literal sense, a luxury that Lesotho’s patients cannot afford.
On the Flawed Clauses
The provisions on technology preference, tax exemptions, and regulatory alignment draw particular criticism, but this too collapses under scrutiny. U.S. technologies built the systems Lesotho currently depends on. FDA approval standards are internationally recognised benchmarks that many countries rely on, formally and informally, because maintaining entirely parallel regulatory infrastructure is expensive and often redundant for small states. Tax exemptions for aid-funded programmes are standard in development finance; the Global Fund and World Bank operate under similar arrangements across Africa.
The procurement preference clause carries the most legitimate basis for scrutiny. Tied aid is a real issue in development economics, and preference clauses can favour donor-country vendors over potentially cheaper alternatives. That is a fair point and worth negotiating at the table. It does not transform a health cooperation agreement into an imperial project. It makes it an agreement with one flawed clause that should be addressed through negotiation, not grounds for wholesale rejection.
Fix the flawed clauses. Sign the agreement. Get back to saving lives.
Parliament’s Legitimate Role
Lesotho’s constitutional reforms are real and worth defending. But defending them does not require manufacturing a constitutional crisis out of a health cooperation framework that builds on decades of existing partnership. Parliament’s legitimate role is to scrutinise, improve, and where necessary amend the terms of agreements, not to indulge the anti-American instincts of critics who would rather perform sovereignty than govern a functioning health system.
The MoU is imperfect. All complex agreements are. But imperfect cooperation with a committed partner is infinitely preferable to principled isolation dressed up as constitutional virtue. Lesotho’s people deserve better than the conspiracy thinking, the utopian obstruction, and the hostility toward the country that has, whatever its faults, consistently been there when the health system needed support.


